Kotaro Shirakawa

6PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMedical virologyGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 11, 2025
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice.

Yoshihito Horisawa, Tadahiko Matsumoto, June Takeda

|Oct 05, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.

Izumi Kimura, Daichi Yamasoba, Hesham Nasser

|Nov 26, 2022
Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice.

Kayoko Nagata, Daichi Utsumi, Masamitsu N Asaka

|Jul 06, 2022
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.

Ryota Maeda, Junso Fujita, Yoshinobu Konishi

|Nov 25, 2021
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Akatsuki Saito, Takashi Irie, Rigel Suzuki

|Jan 28, 2021
CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.

Hiroyuki Matsui, Kotaro Shirakawa, Yoshinobu Konishi

Pageof 1

Frequent Collaborators

4 joint publications

Kei Sato

4 joint publications

Akifumi Takaori-Kondo

3 joint publications

Yasuhiro Kazuma

2 joint publications

Akatsuki Saito